Renew Your Membership

Jeff C. Trost, MD

REVIVED and STICH: Revascularization Versus Guideline Directed Medical Therapy in Ischemic Left Ventricular Systolic Dysfunction

Nov 29, 2022   |  Rawan Amir, MBBS; Jeffrey C. Trost, MD; Roger S. Blumenthal, MD, FACC; William E. Boden, MD, FACC; Armin A. Zadeh, MD, PhD, MPH, FACC

Expert Analysis

Editors' Pick

Coronary artery disease (CAD) continues to be the leading cause of heart failure (HF) globally. The concept of salvaging hibernating myocardium in order to improve morbidity and mortality in patients with HF has been a topic of discussion for many...

Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Dyslipidemia, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Atherosclerotic Disease (CAD/PAD), Implantable Devices, SCD/Ventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Lipid Metabolism, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Coronary Artery Disease, Interventions and Imaging, Computed Tomography, Magnetic Resonance Imaging, Nuclear Imaging

Keywords: Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Cardiomyopathies, Confidence Intervals, Constriction, Pathologic, Coronary Artery Bypass, Coronary Artery Disease, Coronary Vessels, Defibrillators, Cost of Illness, Digitalis, Dobutamine, Disease Progression, Follow-Up Studies, Glucose, Heart Failure, Hospitalization, Hydralazine, Hypoglycemic Agents, Ischemia, Incidence, Isosorbide Dinitrate, Magnetic Resonance Imaging, Life Style, Mineralocorticoid Receptor Antagonists, Morbidity, Myocardial Infarction, Neprilysin, Myocardium, Patient Selection, Percutaneous Coronary Intervention, Positron-Emission Tomography, Progression-Free Survival, Random Allocation, Prospective Studies, Receptors, Angiotensin, Stents, Risk Factors, Stroke Volume, Sodium, Symporters, Tomography, Emission-Computed, Single-Photon, Ventricular Function, Left, Ventricular Dysfunction

Optimize Cardiovascular Risk Factors For Prevention of Heart Failure

Apr 21, 2022   |  Julie Coursen, MD; Abdulhamied Alfaddagh, MD, FACC; Roger S. Blumenthal, MD, FACC; Jeffrey C. Trost, MD; Lili A. Barouch, MD, FACC

Expert Analysis

Editors' Pick

Heart failure (HF) is a major cause of morbidity, mortality, and healthcare expense, but HF prevention has been underappreciated in global cardiovascular risk assessment and intervention within preventive cardiology.

Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Atrial Fibrillation/Supraventricular Arrhythmias, Lipid Metabolism, Nonstatins, Acute Heart Failure, Diet, Exercise, Hypertension, Smoking

Keywords: Sodium-Glucose Transporter 2 Inhibitors, Glycated Hemoglobin A, Cardiovascular Diseases, Aminophylline, Body Mass Index, Diabetes Mellitus, Type 2, American Heart Association, Prevalence, Atrial Fibrillation, Blood Pressure, Glycemic Control, Ethnic Groups, Metabolic Syndrome, Physicians, Primary Care, Risk Factors, Heart Disease Risk Factors, Heart Failure, Hospitalization, Risk Assessment, Hypertension, Atherosclerosis, Primary Prevention, Social Class, Exercise, Health Behavior, Risk Reduction Behavior, Primary Health Care, Cholesterol, Cardiology, Counseling, Delivery of Health Care, Life Style, Obesity, Smoking, Diet

Results 1-2 of 2